文献速递头颈外科

是时候通过循环肿瘤HPV DNA改进口咽癌的诊断检查:系统综述与荟萃分析

It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis.
PubMed 文献 · Head Neck · 2023-09-16

该系统综述与荟萃分析检索MEDLINE、Embase和Cochrane Library数据库,纳入13项研究共998例患者,评估ddPCR检测循环肿瘤HPV DNA(ctHPVDNA)诊断HPV阳性口咽鳞状细胞癌的性能。合并敏感度为0.90(95%CI:0.82-0.94),特异度为0.94(95%CI:0.85-0.98),阳性似然比12.6(95%CI:4.9-32.1),阴性似然比0.05(95%CI:0.02-0.13)。作者认为ddPCR检测ctHPVDNA具有良好的准确性、敏感度和特异度。

要点

  • 合并敏感度0.90(95%CI:0.82-0.94),特异度0.94(95%CI:0.85-0.98)。
  • 阳性似然比12.6(95%CI:4.9-32.1),阴性似然比0.05(95%CI:0.02-0.13)。
  • ctHPVDNA动态变化可能为改进诊断和治疗管理提供可靠机会。

核心结论

  • ddPCR检测ctHPVDNA对诊断HPV阳性口咽鳞状细胞癌具有良好的准确性、敏感度和特异度。
  • ctHPVDNA动态变化可能为改进癌症患者的诊断和治疗管理提供可靠机会,并可能为理解肿瘤生物学开辟新视角。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase和Cochrane Library三个数据库。
  • 共纳入13项研究,评估998例患者,其中OPSCC p16+患者729例,p16-对照269例。
  • 目的是评估ddPCR检测ctHPVDNA的敏感度、特异度和准确性,以明确其在HPV+ OPSCC诊断中的临床效用。

主要发现

  • 合并敏感度为0.90(95%CI:0.82-0.94),合并特异度为0.94(95%CI:0.85-0.98)。
  • 阳性似然比为12.6(95%CI:4.9-32.1),阴性似然比为0.05(95%CI:0.02-0.13)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出这些数据来自小型队列。
  • 原文指出现有的ctHPVDNA检测方法尚未完全验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The possibility of detecting circulating tumor HPV DNA (ctHPVDNA) in plasma in patients with oropharyngeal cancer has been demonstrated in several reports. However, these data are from small cohorts and available tests for detection of ctHPVDNA are not fully validated. The aim is to evaluate sensitivity, specificity, and accuracy of ctHPVDNA by ddPCR to define its efficacy in the clinical setting for the diagnosis of HPV + OPSCC. A comprehensive search of three different databases: MEDLINE, Embase, and Cochrane Library databases. A total of 998 patients were evaluated from the 13 studies. OPSSC p16+ were 729, while controls p16- were 269. The meta-analytic study estimated the diagnostic performance of ctHPVDNA as follows: pooled sensitivity and specificity of 0.90 (95% CI: 0.82-0.94) and 0.94 (95% CI: 0.85-0.98), respectively; positive and negative likelihood ratios of 12.6 (95% CI: 4.9-32.1) and 0.05 (95% CI: 0.02-0.13), respectively. ddPCR for ctHPVDNA has good accuracy, sensitivity, and specificity for diagnosis of HPV + OPSCC. ctHPVDNA kinetic represents a great reliable opportunity to improve diagnostic and therapeutic management of cancer patients and could open new perspectives for understanding tumor biology.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Paolini F, Campo F, Iocca O, et al. It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis. Head Neck. 2023. PMID: 37715656. doi:10.1002/hed.27515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。